Profusa (NASDAQ: PFSA) is extending its footprint in European healthcare with the addition of one of France’s top vascular surgeons…
Read More »Biotech
Shares of uniQure (NASDAQ: QURE) staged one of the most dramatic rallies of the year on Wednesday, more than tripling…
Read More »
Nvidia (NASDAQ: NVDA) hasn’t just ridden the AI wave; it’s helped shape it, on the chip side and, increasingly, through…
Read More »
Profusa (NASDAQ: PFSA) is quickly building momentum across Europe, adding leading vascular specialists to its clinical network while also preparing…
Read More »
Why Profusa Stands Out in Small-Cap Investing Profusa (NASDAQ: PFSA) is a biotech company that is developing tissue‑integrating biosensors for…
Read More »
Bitcoin (BTCUSD) climbed as high as $124,200 on August 14, touching another record high as investors embraced riskier assets amid…
Read More »
Tharimmune (NASDAQ: THAR) stunned Wall Street on Wednesday, with its stock surging more than 200% after announcing positive simulation results…
Read More »
Profusa (NASDAQ: PFSA), a rising player in digital health, just made two bold moves that caught the attention of investors…
Read More »
Shares of Abivax SA (NASDAQ: ABVX) went parabolic on Wednesday, skyrocketing 586% to close at $68.60 after the French biotech…
Read More »
Shares of ProKidney Corp. (NASDAQ: PROK) soared 515% on Tuesday, triggering shockwaves across Wall Street after the company unveiled highly…
Read More »